The Effect of a Short Term Exercise Schedule on Oral Iron Bio-availability and Iron Incorporation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01730521|
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : September 13, 2013
Iron metabolism may undergo changes during exercise, with reductions in classical iron status markers due to a variety of postulated mechanism which include hemodilution, increased iron loss, hemolysis and increased iron storage in muscles. Furthermore, it has been reported that vigorous training increases hepcidin, a central regulatory peptide in iron metabolism. This increase has been ascribed to the presence of subclinical inflammation. Increased hepcidin levels may reduce iron bioavailability and iron incorporation in erythrocytes.
Twenty healthy men subjects will be recruited as subjects for this study. Subjects should be generally healthy, with no history of blood donation in the last 6 months, should weigh less than 85 Kg, and not take iron supplements and/or multivitamin supplements. Subjects should have familiarity to sports and running, but not currently (i.e. in the past 3 months) training for more than 1h per week on average.
The aim of this study is to measure an iron bioavailability during a resting and an exercise phase lasting approx. 14 days with training sessions on alternate days. Subjects will participate in both restign and exercising protocols and act as their own controls during the study. Iron bioavailability will be measured via the incorporation of stable isotopic labels 14 days after administration. To control for changes in blood volume during the course of the study, blood volume of the participating subjects will be measured before and after the exercise phase with the CO-rebreathing method.
Measurement of iron bioavailability and iron incorporation in a resting and exercising phase will allow determine if the increased level of hepcidin seen in in exercise will induce a lower iron bioavailability and iron incorporation during exercise.
|Condition or disease||Intervention/treatment|
|Generally Healthy||Behavioral: Exercise (Running)|
|Study Type :||Observational|
|Actual Enrollment :||10 participants|
|Official Title:||The Effect of a Short Term Exercise Schedule on Oral Iron Bio-availability and Iron Incorporation|
|Study Start Date :||October 2012|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||June 2013|
Difference in Iron bioavailabilty exercise and resting phase
the subjects will act as their own control during the study
Behavioral: Exercise (Running)
the study foresees a measurement of iron biavailability in a resting and in a exercising phase and subjects will act as their own control during the study.
- Iron bioavailability from Stable isotopic labels [ Time Frame: Up to 2 months ]
- Blood volume increase during exercise [ Time Frame: Up to 2 months ]
- Hepcidin levels and inflammation markers (C-Reactive Protein, 1-Alpha acid glycoprotein) [ Time Frame: Up to 2 months ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01730521
|Zürich, Switzerland, 8092|
|Principal Investigator:||Diego Moretti, PhD||University of Zurich|